Clinical Trial Detail

NCT ID NCT03070301
Title A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Memorial Sloan Kettering Cancer Center
Indications

neuroendocrine tumor

Therapies

Everolimus + Ribociclib

Age Groups: adult senior

No variant requirements are available.